Insider Transactions in Q2 2022 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+0.93%
|
$9,216
$8.03 P/Share
|
|
Jun 30
2022
|
William Richard White Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+20.64%
|
$9,216
$8.03 P/Share
|
|
Jun 30
2022
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+0.47%
|
$9,216
$8.03 P/Share
|
|
Jun 30
2022
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,152
+0.37%
|
$9,216
$8.03 P/Share
|